Dengue Drug

The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization programme after the French drugmaker said it could actually worsen the disease in some cases.

The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged overcharging of a dengue patient by its hospital in Gurugram.

Sun Pharma has inked a pact with International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a novel botanical drug for the treatment of dengue, which could hit the market in four years.

The federal government on Friday moved to clear the way for the release of genetically engineered mosquitoes into the wild for the first time in the United States, tentatively approving a field test that might help slow the spread of the Zika virus.

No existing drug can treat the dreaded mosquito-borne disease dengue. But, in a significant development, a team of Indian scientists claims to have developed a drug that can possibly cure dengue. The drug, if put through human clinical trials now, will be available after two years.

In a breakthrough move that can help in the fight against dengue, a herbal medicine against it is claimed to have been developed by scientists in India, which accounts for 50 per cent of the global population estimated to be at risk from the disease.

Sanofi Pasteur, the vaccines division of Sanofi, on Wednesday said the Food and Drug Administration of Philippines has granted marketing approval to its Dengvaxia vaccine to be licensed for the prevention of dengue in Asia.

Serum Institute of India, Asia's largest vaccine maker, plans to file for fast-track approval to launch a dengue treatment in India, its chief executive said, potentially becoming the first company globally to launch a drug for the mosquito-borne virus.

Dengue virus is estimated to infect up to 400 million people globally each year. The World Health Organisation ranks it as the most important mosquito-borne viral disease in the world.

Drugs already developed to treat bacterial infection can be re-purposed to cure the mosquito-borne viral disease dengue, Australian researchers have found.

Researchers have developed a paper-based device that changes colour, depending on whether the patient has Ebola, yellow fever or dengue, an advance that can help diagnose the diseases within minutes in remote, low-resource settings.

A British company's plan to unleash hordes of genetically modified mosquitoes in Florida to reduce the threat of dengue fever and other diseases has sparked an outcry from fearful residents.

French drug company Sanofi could unveil a vaccine in September 2012 for Dengue, the breakbone fever that could help prevent 100 m cases of infection each year.

The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization programme after the French drugmaker said it could actually worsen the disease in some cases.

The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged overcharging of a dengue patient by its hospital in Gurugram.

Sun Pharma has inked a pact with International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a novel botanical drug for the treatment of dengue, which could hit the market in four years.

The federal government on Friday moved to clear the way for the release of genetically engineered mosquitoes into the wild for the first time in the United States, tentatively approving a field test that might help slow the spread of the Zika virus.

No existing drug can treat the dreaded mosquito-borne disease dengue. But, in a significant development, a team of Indian scientists claims to have developed a drug that can possibly cure dengue. The drug, if put through human clinical trials now, will be available after two years.

In a breakthrough move that can help in the fight against dengue, a herbal medicine against it is claimed to have been developed by scientists in India, which accounts for 50 per cent of the global population estimated to be at risk from the disease.

Sanofi Pasteur, the vaccines division of Sanofi, on Wednesday said the Food and Drug Administration of Philippines has granted marketing approval to its Dengvaxia vaccine to be licensed for the prevention of dengue in Asia.

Serum Institute of India, Asia's largest vaccine maker, plans to file for fast-track approval to launch a dengue treatment in India, its chief executive said, potentially becoming the first company globally to launch a drug for the mosquito-borne virus.

Dengue virus is estimated to infect up to 400 million people globally each year. The World Health Organisation ranks it as the most important mosquito-borne viral disease in the world.

Drugs already developed to treat bacterial infection can be re-purposed to cure the mosquito-borne viral disease dengue, Australian researchers have found.

Researchers have developed a paper-based device that changes colour, depending on whether the patient has Ebola, yellow fever or dengue, an advance that can help diagnose the diseases within minutes in remote, low-resource settings.

A British company's plan to unleash hordes of genetically modified mosquitoes in Florida to reduce the threat of dengue fever and other diseases has sparked an outcry from fearful residents.

French drug company Sanofi could unveil a vaccine in September 2012 for Dengue, the breakbone fever that could help prevent 100 m cases of infection each year.